Author Archives : Birgit Rogell

Home  >>  Author : Birgit Rogell

Heidelberg University: Intel and Researchers from Heidelberg and Dresden present three new neuromorphic chips

On Februar 20, 2018, Posted by , In Press Releases, With Kommentare deaktiviert für Heidelberg University: Intel and Researchers from Heidelberg and Dresden present three new neuromorphic chips

Researchers from Heidelberg University and TU Dresden, together with Intel Corporation, will reveal three new neuromorphic chips during the NICE Workshop 2018 in the USA. These chips have an extraordinary ability: They are able to mimic important aspects of biological brains by being energy efficient, resilient and able to learn….

DKFZ: European excellence grant for DKFZ researcher

On Februar 19, 2018, Posted by , In Allgemein, With Kommentare deaktiviert für DKFZ: European excellence grant for DKFZ researcher

The ERC Consolidator Grants by the European Research Council (ERC) support excellent researchers to help them consolidate their independent career. Ana Martin-Villalba from the German Cancer Research Center (DKFZ) has now received this prestigious ERC grant. Martin-Villalba will use the €2 million grant to investigate how repair processes can be…

Roche to acquire Flatiron Health to accelerate industry-wide development and delivery of breakthrough medicines for patients with cancer

On Februar 16, 2018, Posted by , In Allgemein, With Kommentare deaktiviert für Roche to acquire Flatiron Health to accelerate industry-wide development and delivery of breakthrough medicines for patients with cancer

Acquisition will bring together two companies committed to improving the lives of cancer patients through the evolving field of healthcare data and analytics The companies will leverage their combined expertise to advance the use of real-world evidence to set new industry standards for oncology research and development Flatiron Health to…

EMBL: Study identifies new diabetes genes

On Februar 15, 2018, Posted by , In Allgemein, With Kommentare deaktiviert für EMBL: Study identifies new diabetes genes

Scientists identify a network of genes that could play an important role in the development of diabetes Scientists used mice to identify 23 genes might play a role in human diabetes. PHOTO: EMBL-EBI/Spencer Phillips Researchers at the European Bioinformatics Institute (EMBL-EBI), with colleagues at the Helmholtz Center Munich and the…

DKFZ: “Lightning protectors” protect cells from oxidative damage

On Februar 15, 2018, Posted by , In Allgemein, With Kommentare deaktiviert für DKFZ: “Lightning protectors” protect cells from oxidative damage

Scientists from the German Cancer Research Center (DKFZ) have been able to unravel how acetylcysteine, a well-known agent used as a cough medication, can protect cells from oxidative stress. In the cell, the substance is rapidly transformed into so-called persulfides. These sulfur compounds unfold their protective effect on the cell…

Sciomics participates in collaborative clinical trials for the treatment of metaphyseal chondrodysplasia type Schmid (MCDS)

On Februar 12, 2018, Posted by , In Allgemein, With Kommentare deaktiviert für Sciomics participates in collaborative clinical trials for the treatment of metaphyseal chondrodysplasia type Schmid (MCDS)

Heidelberg, 12th February, 2018 Multinational consortium has been granted 5.7 Million Euro for the development of novel therapeutic approaches in rare skeletal disorders. Sciomics‘ expertise with the antibody microarray technology herein serves as a valuable tool for biomarker identification and personalized treatment monitoring. The biotechnology company Sciomics GmbH, located in…

Slovakia becomes EMBL member state

On Februar 8, 2018, Posted by , In Allgemein, With Kommentare deaktiviert für Slovakia becomes EMBL member state

EMBL welcomes Slovakia as its 24th member state EMBL welcomed Slovakia as its latest member state on 29 January 2018. The accession of the Slovak Republic to EMBL emphasises the organisation’s commitment to promoting European science and collaboration among researchers. As a member state, Slovakia will receive access to all…

Two Excellent Young Researchers Honoured in Heidelberg

On Februar 8, 2018, Posted by , In Allgemein, With Kommentare deaktiviert für Two Excellent Young Researchers Honoured in Heidelberg

Marieke Essers and Theodore Alexandrov have received Chica and Heinz Schaller Award for basic biomedical research Photo: Rothe Chica und Heinz Schaller Award for basic biomedical research: Dr Marieke Essers (second from right) and Dr Theodore Alexandrov (centre) receiving the award. The award was handed over by the foundation’s Chairperson,…

Affimed Reports New Data for AFM13 from Two Separate Clinical Trials in Hodgkin and CD30-Positive Lymphomas

On Februar 8, 2018, Posted by , In Allgemein, With Kommentare deaktiviert für Affimed Reports New Data for AFM13 from Two Separate Clinical Trials in Hodgkin and CD30-Positive Lymphomas

Heidelberg, Germany, February 1, 2018 – Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies, today reported additional preliminary patient data from two separate clinical studies of its lead NK cell engager candidate AFM13. The data demonstrate that AFM13 was well-tolerated…

Sanofi to acquire Ablynx for €3.9 Billion

On Januar 30, 2018, Posted by , In Press Releases, With Kommentare deaktiviert für Sanofi to acquire Ablynx for €3.9 Billion

Strengthens Sanofi’s R&D strategy with innovative Nanobody® technology platform Expands growing rare blood disorders franchise with Ablynx’s late-stage investigational caplacizumab aTTP treatment Unanimously approved by Sanofi and Ablynx Boards of Directors Paris, France and Ghent, Belgium – January 29, 2018 – Sanofi and Ablynx, a biopharmaceutical company engaged in the…